阑尾脓肿的治疗决策:2025年意大利外科研究学会/意大利急诊与创伤外科学会共识会议结果
该共识由意大利外科研究学会与意大利急诊与创伤外科学会采用改良德尔菲法制定,经3轮匿名远程投票后召开最终面对面共识会议,共识阈值预设为≥80%为共识、≥95%为强共识。共识采纳同一倡议下制定的标准化病理定义和基于影像的分级分类作为参考标准。核心推荐包括:早期阑尾切除是1级蜂窝织炎和小脓肿最确切的治疗,临床稳定低风险患者可接受短期密切监测的保守治疗试验;大于3-4 cm的脓肿,影像引导经皮穿刺引流被选择性推荐作为高风险手术候选者的暂时性桥接而非确定性治疗;肠系膜脓肿因解剖包裹有限和进展迅速被视为特别高风险,早期手术源控制被认为是最可靠策略;临床不稳定或弥漫性腹膜炎是不论脓肿形态均需立即手术的绝对指征。共识还涉及挽救性手术、间期阑尾切除术的选择性作用及延迟手术的最佳时机,支持风险分层而非常规做法。
要点
- 临床不稳定或弥漫性腹膜炎为立即手术的绝对指征,不论脓肿形态如何。
- 早期阑尾切除被认为是1级蜂窝织炎和小脓肿最确切的治疗;临床稳定低风险患者可接受短期密切监测的保守治疗试验。
- 对于大于3-4 cm的脓肿,影像引导经皮穿刺引流被选择性推荐作为高风险手术候选者的暂时性桥接,而非确定性治疗。
- 肠系膜脓肿因解剖包裹有限和进展迅速被视为特别高风险,早期手术源控制被认为是最可靠策略。
- 共识支持风险分层而非常规做法,涉及挽救性手术、间期阑尾切除术的选择性作用及延迟手术的最佳时机。
适用人群与场景
- 急诊手术中阑尾脓肿患者,因解剖表现、炎症严重程度和患者生理储备存在异质性。
诊断标准与关键阈值
- 共识采纳同一倡议下制定的标准化病理定义和基于影像的分级分类作为参考标准。
- 临床不稳定或弥漫性腹膜炎是不论脓肿形态均需立即手术的绝对指征。
处置流程与药物剂量
- 早期阑尾切除被认为是1级蜂窝织炎和小脓肿最确切的治疗。
- 临床稳定低风险患者可接受短期密切监测的保守治疗试验。
- 对于大于3-4 cm的脓肿,影像引导经皮穿刺引流被选择性推荐作为高风险手术候选者的暂时性桥接,而非确定性治疗。
- 肠系膜脓肿因解剖包裹有限和进展迅速被视为特别高风险,早期手术源控制被认为是最可靠策略。
- 共识支持风险分层而非常规做法,涉及挽救性手术、间期阑尾切除术的选择性作用及延迟手术的最佳时机。
红旗征与不能漏的情况
- 临床不稳定或弥漫性腹膜炎是不论脓肿形态均需立即手术的绝对指征。
- 肠系膜脓肿因解剖包裹有限和进展迅速被视为特别高风险。
研究设计与关键结果
- 该共识采用改良德尔菲法,包括3轮匿名远程投票,随后召开最终面对面共识会议,共识阈值预设为≥80%为共识、≥95%为强共识。
证据类型、等级与局限
- 证据类型:学会共识(改良德尔菲法)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 临床不稳定或弥漫性腹膜炎患者应不论脓肿形态立即手术。
- 1级蜂窝织炎和小脓肿以早期阑尾切除为最确切治疗,临床稳定低风险患者可考虑短期密切监测的保守治疗试验。
- 大于3-4 cm的脓肿在高风险手术候选者中可选择性使用影像引导经皮穿刺引流作为暂时性桥接,而非确定性治疗。
- 肠系膜脓肿应优先考虑早期手术源控制。
- 共识支持风险分层而非常规做法,涉及挽救性手术、间期阑尾切除术及延迟手术时机。
指南或共识出处
- 2025年意大利外科研究学会/意大利急诊与创伤外科学会共识会议。
提炼说明
- 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The management of appendiceal abscess remains a challenging area in emergency surgery because of heterogeneity in anatomic presentation, inflammatory severity, and patient physiologic reserve. The absence of standardized pathologic definitions, imaging-based grading systems, and clear escalation criteria has contributed to substantial variability in clinical practice. A unified, physiology-driven framework is therefore needed to support transparent and reproducible decision-making.
METHODS: This study represents the management-focused component of the Italian Society of Research in Surgery-Italian Society of Emergency and Trauma Surgery consensus initiative on appendiceal abscess. A modified Delphi methodology was applied, including 3 rounds of anonymous remote voting, followed by a final in-person consensus meeting. Standardized pathologic definitions and an imaging-based grading classification developed within the same initiative were adopted as reference standards. Agreement thresholds were predefined: ≥80% indicating consensus and ≥95% strong consensus.
RESULTS: Early appendectomy was considered the most definitive treatment for grade 1 phlegmons and small abscesses, although a short, closely monitored trial of conservative management may be acceptable in clinically stable, low-risk patients. For abscesses larger than 3-4 cm, image-guided percutaneous drainage was selectively recommended as a temporizing bridge in high-risk surgical candidates rather than as definitive therapy. Mesenteric abscesses were identified as particularly high risk because of limited anatomic containment and rapid progression, and early surgical source control was considered the most reliable strategy. Clinical instability or generalized peritonitis represented absolute indications for immediate surgery, regardless of abscess morphology. The panel also addressed salvage surgery, the selective role of interval appendectomy, and the optimal timing of delayed surgery, supporting a risk-stratified rather than routine approach.
CONCLUSION: This consensus provides a reproducible, physiology-driven framework for the management of appendiceal abscess, integrating anatomic patterns, radiologic grading, and explicit escalation criteria. These recommendations aim to reduce unwarranted variability and improve the consistency and quality of care.
参考来源
- Cirocchi R, Matteucci M, Rizzuto A, et al. Therapeutic decision-making in appendiceal abscess: Results of the 2025 Italian Society of Research in Surgery/Italian Society of Emergency and Trauma Surgery consensus conference. Surgery. 2026. PMID: 42617507. doi:10.1016/j.surg.2026.110470
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。